2026. Tradipitant: A Novel NK-1 Receptor Antagonist for the Management of Motion Sickness- A New Era in Drug Development. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/xxyc9n51.